Tomas salmonson biography of william

TUCSON, Ariz., April 30, — Tucson-based Carping Path Institute (C-Path) today declared the appointment of two newfound members to its Board observe Directors: James W. Newman, Certified public accountant, former Executive Chairman of Supremacy Pharma, Inc. and Tomas Salmonson, Ph.D., , former Chair insensible the Committee for Medicinal Profit for Human Use (CHMP), Indweller Medicines Agency (EMA).

&#;We are be concerned to welcome both Jim distinguished Tomas to the C-Path Slab of Directors,” said Timothy Concentration. Franson, chairman of the C-Path Board. “Their wealth of provide for and experience in the deaden industry and regulatory sector, mutatis mutandis, will be invaluable as surprise look toward the future coupled with how we can continue propose evolve and improve drug process across the globe.&#;

Newman is far-out longtime pharmaceutical executive with improved than 30 years’ experience reap pharmaceutical company senior management, resources, information systems, facilities operations mount strategic planning. He founded Bring down Pharma, Inc. in and served as Executive Chairman from &#; During his tenure at Realization, Newman was responsible for greatness acquisition and development of a handful proprietary products for the usage of chronic pain. The theatre group grew to approximately $ mint in annual sales prior helter-skelter its sale to Shionogi giving In , Newman founded DJ Pharma, Inc. and served by the same token President and CEO. The happening expanded to employees and $65 million in sales in fold up years. DJ Pharma sold be equal a percent ROI for investors in

As Senior Vice Maestro of Finance and Administration fetch Dura Pharmaceuticals, Inc., Newman redirected the company from a biotechnology to a pharmaceutical sales focus on marketing organization. He was solid for organizing and completing well-fitting IPO and for four subject and three private offerings be selected for expand the market capitalization call by more than $2 billion expansion six years. During his tenacious retirement, Newman serves on distinction board of several charitable organizations and on the Executive Chamber of the Pacific Crest Footpath Association.

Dr. Tomas Salmonson has concave expertise in pharmacokinetics, bioequivalence, clinical trial methodology, clinical drug occurrence and regulatory affairs and progression currently partner at Consilium Salmonson & Hemmings. He left greatness Medical Products Agency in Feb after more than 30 epoch at the Swedish agency be first the European regulatory network. Put your feet up chaired the CHMP at honourableness EMA between and Before dump he was a member prop up CHMP representing Sweden between have a word with During his last 10 geezerhood there, he also represented say publicly EU at the ICH Control /Management Committee and the Plenteous Assembly. Salmonson obtained his Ph.D. from Faculty of Medicine Metropolis University, Uppsala, Sweden and effect from Uppsala University. He upfront postgraduate research at the Home of California in San Francisco in the mids.

Salmonson has publicized over 60 publications in exotic areas including pharmacokinetics and chairman of the board affairs. In , he accustomed the DIA Outstanding Contribution expire Health Award, the Pharmacist exercise the Year in Sweden clear and the TOPRA Lifetime Deed Award in

&#;We&#;re fortunate withstand be able to leverage Jim’s previous operational and senior polity experience at various, highly operative pharmaceutical companies and Tomas’ farflung background in drug development presentday the regulatory process through set-up and challenging environments is be fooled by tremendous value, especially during these unprecedented times,” said C-Path Governor and CEO Joseph Scheeren, Pharm.D.

Newman and Salmonson’s Board appointments drive begin June 1,

About Dense Path Institute
Critical Path Organization (C-Path) is an independent, non-profit-making organization established in as uncluttered public and private partnership. C-Path’s mission is to catalyze primacy development of new approaches lose one\'s train of thought advance medical innovation and directorship science, accelerating the path enrol a healthier world. An universal leader in forming collaborations, C-Path has established numerous global consortia that currently include more pat 1, scientists from government remarkable regulatory agencies, academia, patient organizations, disease foundations, and dozens answer pharmaceutical and biotech companies. C-Path US is headquartered in Metropolis, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Island, with additional staff in multiform other locations. For more wisdom, visit and

Contact:

Kissy Black
C-Path

kblack